Improvement of leukemia-free survival (ITS) and reduction of relapse incidence by allogeneic stem cell transplantation (SCT) in elderly patients (pts) with AML, irrespective of the FLT3-ITD and npm status except npm+/flt3(ITD)-

被引：0
|
作者：
Niederwieser, O.
Schueler, F.
Hegenbart, U.
Maschmeyer, G.
Fischer, T.
Junghanss, C.
Wolf, H.
Sayer, H. G.
Kreibich, U.
Doelken, G.
机构：
[1] Univ Leipzig, Dept Hematol Oncol & Hemostasis, D-04109 Leipzig, Germany
[2] Univ Hosp, Leipzig, Germany
[3] Amyloidosis Ctr, Heidelberg, Germany
[4] Potsdam Klinikum, Potsdam, Germany
[5] Univ Magdeburg, D-39106 Magdeburg, Germany
[6] Univ Rostock, D-18055 Rostock, Germany
[7] Univ Halle Wittenberg, D-06108 Halle, Germany
[8] Jena Uniklinikum, Jena, Germany
[9] Braun Krankenhaus, Zwickau, Germany
[10] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6505
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML
    Garg, Swati
    Reyes-Palomares, Armando
    He, Lixiazi
    Bergeron, Anne
    Lavallee, Vincent-Philippe
    Lemieux, Sebastien
    Gendron, Patrick
    Rohde, Christian
    Xia, Jianglong
    Jagdhane, Prarabdha
    Mueller-Tidow, Carsten
    Lipka, Daniel B.
    Imren, Suzan
    Humphries, R. Keith
    Waskow, Claudia
    Vick, Binje
    Jeremias, Irmela
    Richard-Carpentier, Guillaume
    Hebert, Josee
    Sauvageau, Guy
    Zaugg, Judith B.
    Barabe, Frederic
    Pabst, Caroline
    BLOOD, 2019, 134 (03) : 263 - 276
  • [42] Allogeneic stem cell transplantation and targeted therapy for FLT3/ITD+ acute myeloid leukemia: an update
    Hu, Bei
    Vikas, Praveen
    Mohty, Mohamad
    Savani, Bipin N.
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (02) : 301 - 315
  • [43] Measurable residual disease status and FLT3 inhibitor therapy in patients with FLT3-ITD mutated AML following allogeneic hematopoietic cell transplantation (vol 56, pg 3091, 2021)
    Liang, Emily C.
    Chen, Connie
    Lu, Rong
    Mannis, Gabriel N.
    Muffly, Lori
    BONE MARROW TRANSPLANTATION, 2022, 57 (04) : 694 - 694
  • [44] Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation
    Grzegorz Helbig
    Anna Koclęga
    Agata Wieczorkiewicz-Kabut
    Krzysztof Woźniczka
    Anna Kopińska
    Kinga Boral
    Iwona Grygoruk-Wiśniowska
    Małgorzata Stachowicz
    Agnieszka Karolczyk
    Annals of Hematology, 2020, 99 : 1845 - 1853
  • [45] Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation
    Helbig, Grzegorz
    Koclega, Anna
    Wieczorkiewicz-Kabut, Agata
    Wozniczka, Krzysztof
    Kopinska, Anna
    Boral, Kinga
    Grygoruk-Wisniowska, Iwona
    Stachowicz, Malgorzata
    Karolczyk, Agnieszka
    ANNALS OF HEMATOLOGY, 2020, 99 (08) : 1845 - 1853
  • [46] Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD
    Ho, Anthony D.
    Schetelig, Johannes
    Bochtler, Tilmann
    Schaich, Markus
    Schaefer-Eckart, Kerstin
    Haenel, Mathias
    Roesler, Wolf
    Einsele, Hermann
    Kaufmann, Martin
    Serve, Hubert
    Berde, Wolfgang E.
    Stelljes, Matthias
    Mayer, Jiri
    Reichle, Albrecht
    Baldus, Claudia D.
    Schmitz, Norbert
    Kramer, Michael
    Roellig, Christoph
    Bornhaeuser, Martin
    Thiede, Christian
    Ehninger, Gerhard
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : 462 - 469
  • [47] Impact of FLT3-ITD Mutations in Patients with Normal Karyotype Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation
    Grillo, Giovanni
    Zucchetti, Elisa
    Inzoli, Elena
    Mancini, Valentina
    Forno, Barbara
    Lotesoriere, Ivana
    Bertani, Giambattista
    Cairoli, Roberto
    BLOOD, 2017, 130
  • [48] Effect of Sorafenib on the Outcomes of Patients With FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Xuan, Li
    Wang, Yu
    Huang, Fen
    Jiang, Erlie
    Deng, Lan
    Wu, Bingyi
    Fan, Zhiping
    Liang, Xinquan
    Xu, Na
    Ye, Jieyu
    Lin, Ren
    Yin, Changxin
    Zhang, Yuanyuan
    Sun, Jing
    Han, Mingzhe
    Huang, Xiaojun
    Liu, Qifa
    CANCER, 2018, 124 (09) : 1954 - 1963
  • [49] Allogeneic Hematopoietic Cell Transplantation in AML with Normal Karyotype and NPM1 Mutated FLT3-ITD Negative: A Retrospective Analysis from the Acute Leukemia Working Party of EBMT
    Bazarbachi, Ali
    Labopin, Myriam
    Kharfan-Dabaja, Mohamed A.
    Schwerdtfeger, Rainer
    Volin, Liisa
    Bourhis, Jean-Henri
    Socie, Gerard
    Deconinck, Eric
    Gedde-Dahl, Tobias
    Rambaldi, Alessandro
    Jindra, Pavel
    Schlimok, Guenter
    Blaise, Didier
    Chevallier, Patrice
    Nagler, Arnon
    Schmid, Christoph
    Esteve, Jordi
    Mohty, Mohamad
    BLOOD, 2014, 124 (21)
  • [50] Allogeneic Stem Cell Transplantation in Patients With FLT3-ITD Mutated AML: Transplantation in CR1 Is the Decisive Factor for Good Outcome
    Jindra, Pavel
    Raida, Ludek
    Karas, Michal
    Szotkowski, Tomas
    Lysak, Daniel
    Hrabetova, Marcela
    Jungova, Alexandra
    Steinerova, Katerina
    Faber, Edgar
    Papajik, Tomas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (07): : 462 - 469
12345